A study of combination of insulin lispro with exenatide.
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Exenatide/insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- 31 Jan 2017 New trial record
- 05 Jan 2017 According to an Adocia media release, this trial is expected to start in Q4 2017.